Listen. Learn. Take Responsibility.
Read our message on racial equity.

Boris Peaker, Ph.D., CFA

Managing Director, Health Care - Biotechnology

Boris Peaker is a managing director and senior research analyst covering emerging growth biotechnology companies. Prior to rejoining Cowen in 2014, Dr. Peaker was a senior analyst at Oppenheimer & Co. and Rodman & Renshaw, covering large-, mid-, and small-cap biotechnology stocks. Dr. Peaker holds a BS in physics and chemistry from Stony Brook University and a Ph.D. in biophysics from Stanford University. He is a CFA charterholder.

Get In Touch

Start a conversation with Boris Peaker

Insights

Explore related thought leadership, reports, coverage and insights for Boris Peaker.

Prescription drug tablets on a black surface
Ahead of the Curve®

2020 Drug Pricing Survey, 25th Annual

Read More
Ahead of the Curve®

Second Annual Novel Immuno-Oncology Targets Survey

Read More
Ahead of the Curve®

Opioid Primer: Cowen’s Analysis Of The Opioid Crisis

Read More

Research Contacts

Our Research team is led by seasoned, entrepreneurial-minded individuals who are driven by a relentless curiosity to redefine expectations.

Meet Our People
Senior businessman handshaking with young woman in the office